Petra M. Nederlof Sign in to save

ORCID 0000-0002-2358-9765 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (6)

3× Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1× Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands
1× Department of Molecular Diagnostics, Netherlands Cancer Institute, Amsterdam, The Netherlands
1× Department of Molecular diagnostics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1× Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
1× Department of Pathology The Netherlands Cancer Institute Amsterdam The Netherlands

Papers 7 stored

All · Aachen affiliation only

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial
2026 The Lancet Oncology article Medicine PARP inhibition in cancer therapy

2

citations
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status
2024 BMC Medicine article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

5

citations
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
2023 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

5

citations
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
2022 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

41

citations
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)
2021 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

9

citations
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
2020 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

34

citations
Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐ BRCA1 /2 sib trios affected with breast cancer
2020 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access

2

citations

7 results

Petra M. Nederlof ▲ Sign in to save

Departments & institutes in Aachen

Papers 7 stored

Petra M. Nederlof Sign in to save